Action against AbbVie. Money that could treat HIV patients ‘goes up in smoke’ in Kiev
Call to action NewsActivists gathered outside a Kiev Court to highlight the huge amount of money being wasted on an overpriced drug, due...
-
Activists fear looming health crisis in Argentina – call on IMF to act
Call to action NewsToday global health activists took to the streets in Washington DC to highlight the looming health crisis facing the people...
Read more about Activists fear looming health crisis in Argentina – call on IMF to act
-
The people against Gilead. Activists protest at the Brazilian patent office, calling for Gilead’s last sofosbuvir patent application to be rejected
Call to action NewsActivists gathered at the Brazilian Patent Office (INPI) in Rio de Janeiro this week, and Gilead’s office in São Paulo....
-
When will ViiV, Clinton Health and partners officially repair the mistake on missing out 39 countries from the DTG pricing agreement?
Call to action NewsIt has been six months since we alerted the Clinton Health Access Initiative (CHAI) to a glaring omission in the...
-
ICASA 2017: Optimal HIV treatment for ALL
Call to action NewsAs the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
-
“Southern Africa must be innovative to tackle access to HIV and TB treatment” says ARASA
Call to action NewsThe right to life is being denied due to high prices for medicines. Addressing pharmaceuticals’ abuse of intellectual property law...
-
Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
Call to action NewsAbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
Read more about Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
-
African treatment advocates call on ViiV Healthcare to unlock access to dolutegravir for North Africa now
Call to action NewsOn 1 December 2015 in Harare , at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates...
